“Check Ligament Suspension for Severe Congenital Blepharoptosis”

兔眼 医学 外科 上睑下垂 韧带 眼睑 内翻
作者
Zheng-Qiang Cang,Dongyue Hao,Jiao Cao,Li‐Ming Sun,Xiao Fan,Ying Ma,Bao-Qiang Song,Pai Peng,Chao-Hua Liu
出处
期刊:Plastic and Reconstructive Surgery [Lippincott Williams & Wilkins]
标识
DOI:10.1097/prs.0000000000012166
摘要

Background: Check ligament suspension has been expected to become an alternative to frontalis technique. However, it has not yet been widely used because of anatomical controversies, concerns regarding its reliability, and the risk of conjunctival prolapse. This article details the authors’ experience with the use of check ligament suspension for the treatment of severe congenital ptosis, and evaluates the functional and cosmetic results. Methods: This was a single institution retrospective study that included patients who underwent check ligament suspension for severe congenital blepharoptosis from July of 2021 to June of 2023. Preoperative data collected included age, sex, margin reflex distance 1 (MRD1), levator function, and lagophthalmos. Postoperative evaluation including correction result, eyelid closure function, cosmetic result was performed at the last follow-up. Results: A total of 124 patients (170 eyes) were included in this study. There was a significant improvement between the post- and pre-operative MRD1, and 159 eyes (93.6 percent) showed successful correction. Postoperatively, the mean residual lagophthalmos was 0.58 ±0.57 mm, and 162 eyes (95.3 percent) showed excellent or good eyelid closure function. The average cosmetic result score was 8.45 ± 1.11, and 107 patients (86.3 percent) had an excellent or good cosmetic result. Conclusions: The check ligament suspension, utilizing the understanding of the extraocular check ligament system to perform the procedure in an effective and anatomically logical manner, has been proven to achieve sufficient corrective result for severe congenital ptosis with good cosmetic result and minimal complications such as under-correction, residual lagophthalmos, and conjunctival prolapse. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
1秒前
2秒前
Guochunbao完成签到,获得积分10
2秒前
corner发布了新的文献求助10
2秒前
3秒前
light完成签到 ,获得积分10
3秒前
情怀应助迷路雨竹采纳,获得10
4秒前
FashionBoy应助张东方采纳,获得10
4秒前
SciGPT应助科研通管家采纳,获得10
4秒前
科研通AI5应助科研通管家采纳,获得10
4秒前
斯文败类应助科研通管家采纳,获得10
4秒前
彭于晏应助科研通管家采纳,获得10
4秒前
香蕉觅云应助科研通管家采纳,获得20
4秒前
打打应助科研通管家采纳,获得10
4秒前
Orange应助科研通管家采纳,获得10
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
乐乐应助科研通管家采纳,获得10
5秒前
共享精神应助如常采纳,获得10
5秒前
5秒前
Dean应助科研通管家采纳,获得50
5秒前
科研通AI5应助科研通管家采纳,获得10
5秒前
大模型应助科研通管家采纳,获得10
5秒前
5秒前
传奇3应助科研通管家采纳,获得10
6秒前
科研通AI5应助迷路的鞅采纳,获得10
6秒前
勤劳冰烟应助科研通管家采纳,获得10
6秒前
天真慕灵完成签到,获得积分10
6秒前
Criminology34应助科研通管家采纳,获得30
6秒前
浮游应助科研通管家采纳,获得10
6秒前
bkagyin应助科研通管家采纳,获得10
6秒前
Criminology34应助科研通管家采纳,获得10
6秒前
ding应助456采纳,获得10
6秒前
科研通AI6应助科研通管家采纳,获得150
6秒前
yyi1应助科研通管家采纳,获得50
6秒前
田様应助科研通管家采纳,获得10
6秒前
6秒前
6秒前
XB发布了新的文献求助10
7秒前
乐乐应助由由采纳,获得10
8秒前
善学以致用应助玛卡巴卡采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5061662
求助须知:如何正确求助?哪些是违规求助? 4285676
关于积分的说明 13355244
捐赠科研通 4103562
什么是DOI,文献DOI怎么找? 2246765
邀请新用户注册赠送积分活动 1252500
关于科研通互助平台的介绍 1183346